Ocular Therapeutix
OCUL
$5.50
Share price
9.56%
Change (1 day)
-11.00%
Change (1 year)
Categories
Ocular Therapeutix (OCUL) - P/B ratio
P/B ratio as of May 2024 : 8.52
According to Ocular Therapeutix's latest financial reports the company has a price-to-book ratio of 8.52.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Ocular Therapeutix - P/B ratio (from 2014 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 5.62 | -8.11% |
| 2022-12-31 | 6.12 | 0.8% |
| 2021-12-31 | 6.07 | -70.65% |
| 2020-12-31 | 20.7 | -137.75% |
| 2019-12-31 | -54.8 | -1289.1% |
| 2018-12-31 | 4.61 | -8.06% |
| 2017-12-31 | 5.01 | 25.12% |
| 2016-12-31 | 4.00 | 54.68% |
| 2015-12-31 | 2.59 | -69.72% |
| 2014-12-31 | 8.55 | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 SurModics SRDX | 3.88 | -54.42% | 🇺🇸 USA |
 Anika Therapeutics ANIK | 1.85 | -78.29% | 🇺🇸 USA |
 Haemonetics HAE | 4.96 | -41.80% | 🇺🇸 USA |